AnalystBook Research · Company Intelligence

HENRY SCHEIN INC

HSICNasdaq

Built from HENRY SCHEIN INC's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data

Henry Schein: Revenue grew 4.0% to $13.184B from $12.673B. Net income grew 2.1% to $398M from $390M. Free cash flow declined 18.1% to $573M from $700M. Operating margin expanded 5 bps to 4.95%. Henry Schein's annual comparison also shows free cash flow declined despite revenue growth; inventory grew faster than revenue.

The read at a glance✓ Audited against SEC data
  • Growth — Revenue grew 4.0%OK
  • Profitability — Net income grew 2.1% to $398M from $390MOK
  • Cash flow — Free cash flow declined 18.1% to $573M from $700MWatch
  • Margins — Operating margin expanded 5 bps to 4.95%OK
  • Accounting — No overriding statistical warningNote
  • Insiders — 2 purchases and 7 salesOK

Business

Henry Schein distributes dental and medical products and provides practice technology and services.

Where the revenue comes from

Fiscal 2025, as HENRY SCHEIN INC reports it. History and quarterly detail are in the app.

  • Global Distribution and Value-Added Services$11.1B
  • Global Specialty Products$1.5B
  • Global Technology$675.0M

Leadership changes

From HENRY SCHEIN INC's own filings, the day they're filed.

  • Frederick Lowery · Chief Executive Officer · appointmenteff. 2026-03-02
  • Stanley M. Bergman · Chief Executive Officer · departureeff. 2025-12-31
  • Max Lin · director · appointmenteff. 2025-05-02

Latest filings

  • 8-K · Company announcement2026-08-04
  • 10-Q · Quarterly report2026-08-04
  • 8-K · Company announcement2026-07-30
  • 8-K · Company announcement2026-05-22
  • 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about HENRY SCHEIN INC, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

See the full HSIC record — start free

14-day free trial, no credit card. For research purposes only; not investment advice.